USCOM Ltd (ASX: UCM) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
USCOM Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$8.02 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
250.48 million
Earnings per share
-0.012
Dividend per share
N/A
Year To Date Return
-21.95%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
USCOM Ltd (ASX: UCM)
Latest News
Healthcare Shares
The Uscom (ASX:UCM) share price plunged 6% today. Here's why
Share Gainers
These ASX shares are fighting the spread of coronavirus
Share Gainers
Why this small-cap ASX healthcare share surged 39% higher today
UCM ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About USCOM Ltd
USCOM Ltd is engaged in the development, design, manufacture, and marketing of premium non-invasive cardiovascular and pulmonary medical devices. The company's geographical segment includes Australia, Asia, America, Europe, and Other regions. The company generates maximum revenue from Australia. The company offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, SPIROSONIC, a pulmonary function testing device based on multi-path ultrasound technology.
UCM Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 26 Nov 2024 | $0.03 | $0.00 | 0.00% | 1,000 | $0.03 | $0.03 | $0.03 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 25 Oct 2024 | Robert Phillips | Issued | 9,670,117 | $250,027 |
Director remuneration. 9,670,117 performance rights
|
| 03 Jul 2024 | Robert Phillips | Exercise | 4,756,891 | $85,624 |
Conversion of securities.
|
| 03 Jul 2024 | Robert Phillips | Issued | 4,756,891 | $85,624 |
Conversion of securities.
|
| 05 Mar 2024 | Robert Phillips | Issued | 18,802,525 | $695,693 |
Rights issue. As per announcement on 05-04-2024
|
| 04 Mar 2024 | Robert Phillips | Issued | 13,495,411 | $499,330 |
Rights issue. As per announcement on 04-03-2024
|
| 04 Mar 2024 | Xianhui Meng | Issued | 12,238,013 | $452,806 |
Rights issue.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Brett Thomas Crowley | Company SecretaryNon Executive director | May 2016 |
Mr Crowley is a practicing solicitor and a former Partner of Ernst & Young in Hong Kong and Australia, and of KPMG in Hong Kong and has worked in China establishing and managing JV companies there. Mr Crowley is an experienced chairman, finance director and company secretary of ASX-listed companies and is a former Senior Legal Member of the NSW Civil and Administrative Tribunal.
|
| Mr Robert Allan Phillips | Chief Executive OfficerExecutive ChairmanExecutive Director | Nov 2011 |
Mr Phillips has 20 years of experience in corporate management since taking Uscom public in 2003 and has taken the company global with regional headquarters in Singapore, Beijing and Budapest with offices in Delawere.
|
| Mr Christian R Bernecker | Non-Executive Director | Nov 2011 |
Mr Bernecker has more than 10 years of broad investment experience across capital raising, acquisitions and divestments.
|
| Mr Xianhui Meng | Non-Executive Director | Dec 2019 |
Mr Meng has 10 years of experience as a China government departmental head, and 20 years of experience as the Executive Manager and Executive Director of a HK Listed Chinese Pharma specialising in sales and distribution. Mr Meng brings both his international corporate management and strategic skills to the Uscom Board.
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Mr Robert Allan Phillips | 83,556,804 | 33.51% |
| Citicorp Nominees Pty Limited | 55,452,884 | 22.24% |
| Neja Pty Ltd | 17,633,368 | 7.07% |
| HSBC Custody Nominees (Australia) Limited A/C 2 | 8,539,336 | 3.42% |
| Jetan Pty Ltd <G R Plummer Super Fund A/C> | 8,357,143 | 3.35% |
| Invia Custodian Pty Limited <Bozwald Pty Ltd A/C> | 4,228,931 | 1.70% |
| Invia Custodian Pty Limited <Riverbel Family No 3 A/C> | 3,490,141 | 1.40% |
| Mr David Leroy Boyles | 3,000,000 | 1.20% |
| Ms Pamela Jack | 2,845,212 | 1.14% |
| Mr Douglas James Cameron | 2,672,432 | 1.07% |
| Mr Dongjun Sun | 2,414,125 | 0.97% |
| Mrs Christine Quye | 2,268,150 | 0.91% |
| Mr Rutherford James Browne & Mrs Sheba Elizabeth Marjorie Browne | 2,121,991 | 0.85% |
| Mr Perry Julian Rosenzweig | 1,820,711 | 0.73% |
| Mr Dean Leon Burrows & Mrs Kerry Ann Burrows | 1,500,000 | 0.60% |
| Mr Christopher James Were & Lockhart Trustee Services No 17 Limited <Christopher Were Family A/C> | 1,424,095 | 0.57% |
| Trentham Super Pty Ltd <Trentham Sf A/C> | 1,351,000 | 0.54% |
| Dr Choon Joo Kho | 1,317,718 | 0.53% |
| Mr Donald Allan Hammond | 1,225,000 | 0.49% |
| Mr Douglas James Cameron i | 1,206,505 | 0.48% |
